Haemonetics Corporation (HAE)
NYSE: HAE
· Real-Time Price · USD
53.11
0.78 (1.49%)
At close: Aug 15, 2025, 10:00 AM
Haemonetics Income Statement
Financials in USD. Fiscal
year is
May - April.
| Fiscal Year | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 28, 2025 | Mar 29, 2025 | Dec 28, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 30, 2023 | Sep 30, 2023 | Jul 1, 2023 | Apr 1, 2023 | Dec 31, 2022 | Oct 1, 2022 | Jul 2, 2022 | Apr 2, 2022 | Jan 1, 2022 | Oct 2, 2021 | Jul 3, 2021 | Apr 3, 2021 | Dec 26, 2020 | Sep 26, 2020 | Jun 27, 2020 |
Revenue | 1.35B | 1.36B | 1.37B | 1.36B | 1.33B | 1.31B | 1.27B | 1.24B | 1.22B | 1.17B | 1.13B | 1.08B | 1.03B | 993.2M | 953.22M | 933.83M | 903.41M | 870.46M | 883.93M | 902.52M | 945.61M |
Cost of Revenue | 591.54M | 611.87M | 646.01M | 649.4M | 639M | 621.81M | 598.29M | 586.5M | 578.43M | 553.56M | 534.09M | 508.7M | 486.45M | 487.69M | 502.23M | 501.13M | 487.52M | 472.63M | 454.34M | 465.14M | 486.97M |
Gross Profit | 754.5M | 748.96M | 727.51M | 711.83M | 694.9M | 687.24M | 671.89M | 652.73M | 640.1M | 615.1M | 595.16M | 575.02M | 539.68M | 505.5M | 451M | 432.69M | 415.89M | 397.84M | 429.59M | 437.38M | 458.64M |
Operating Income | 237.2M | 221.82M | 201.65M | 188.59M | 172.2M | 186.1M | 170.19M | 167.5M | 178.93M | 156.03M | 139.98M | 132.35M | 110.13M | 80.75M | 40.38M | 45.15M | 79.42M | 89.75M | 136.93M | 137.41M | 128.37M |
Interest Income | n/a | 6.96M | 6.96M | 6.96M | 6.96M | 3.38M | 3.38M | 3.38M | 3.38M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 210.53M | 212.07M | 164.75M | 158.86M | 146.99M | 151.87M | 161.08M | 159.27M | 167.5M | 141.4M | 124.1M | 113.27M | 92.13M | 63.63M | 20.91M | 26.89M | 61.92M | 72.91M | 122.27M | 122.72M | 112.86M |
Net Income | 163.34M | 167.68M | 130.06M | 123.81M | 114.89M | 117.56M | 126.57M | 128.28M | 136.57M | 115.4M | 95.76M | 86.05M | 67.71M | 43.38M | 22.59M | 31.24M | 64.49M | 79.47M | 108.13M | 106.15M | 95.53M |
Selling & General & Admin | 438.52M | 436.75M | 427.83M | 433.08M | 431.04M | 416.54M | 407.48M | 390.42M | 377.93M | 376.68M | 371.14M | 357.2M | 340.57M | 339.56M | 331.43M | 324.15M | 320.07M | 298.39M | 293.25M | 298.07M | 296.22M |
Research & Development | 63.85M | 62.72M | 60.8M | 58.24M | 54.37M | 52.57M | 54.22M | 53.65M | 51.88M | 50.13M | 47.7M | 45.05M | 45M | 46.8M | 44.43M | 41.9M | 37.81M | 32.86M | 30.99M | 30.49M | 31.15M |
Other Expenses | 24.49M | 36.97M | 36.97M | 31.65M | 37.02M | 32.02M | 40M | 41.17M | 31.75M | 32.64M | 36.15M | 40.22M | 43.4M | 47.41M | 44.56M | 32.41M | 21M | 8.63M | n/a | n/a | n/a |
Operating Expenses | 526.86M | 523.97M | 513.13M | 510.5M | 499.55M | 490.72M | 491.28M | 474.82M | 461.56M | 459.45M | 454.99M | 442.47M | 428.98M | 433.78M | 420.42M | 398.46M | 378.89M | 339.88M | 324.24M | 328.56M | 327.36M |
Interest Expense | 20.78M | 23.66M | 29.59M | 22.43M | 17.91M | 13.02M | 9.12M | 8.22M | 11.43M | 14.63M | 15.87M | 19.08M | 18M | 17.12M | 19.47M | 18.26M | 17.5M | 16.83M | 14.66M | 14.69M | 15.51M |
Selling & Marketing Expenses | n/a | n/a | 7.1M | 7.1M | 7.1M | 7.1M | 7.2M | 7.2M | 7.2M | 7.2M | 4.4M | 4.4M | 4.4M | 4.4M | 2.7M | 2.7M | 2.7M | 2.7M | 4.3M | 4.3M | 4.3M |
Cost & Expenses | 1.12B | 1.14B | 1.17B | 1.17B | 1.15B | 1.11B | 941.4M | 913.15M | 891.82M | 864.84M | 989.07M | 951.17M | 915.42M | 921.47M | 922.65M | 899.59M | 866.41M | 812.5M | 778.58M | 793.71M | 814.33M |
Income Tax Expense | 47.19M | 44.39M | 34.68M | 35.05M | 32.1M | 34.31M | 34.5M | 31M | 30.93M | 26M | 28.34M | 27.22M | 24.43M | 20.25M | -1.69M | -4.35M | -2.56M | -6.56M | 14.14M | 16.58M | 17.32M |
Shares Outstanding (Basic) | 48.11M | 49.19M | 50.29M | 50.9M | 50.94M | 50.79M | 50.77M | 50.73M | 50.54M | 50.45M | 50.51M | 50.95M | 51.22M | 51.12M | 51.09M | 51.04M | 49.49M | 50.21M | 50.79M | 50.7M | 50.42M |
Shares Outstanding (Diluted) | 48.35M | 49.48M | 50.64M | 51.24M | 51.56M | 51.41M | 51.45M | 51.4M | 51.34M | 51.22M | 51.22M | 51.56M | 51.68M | 51.35M | 51.34M | 51.46M | 50.94M | 50.85M | 51.36M | 51.09M | 51.25M |
EPS (Basic) | 3.29 | 3.33 | 2.56 | 2.43 | 2.26 | 2.32 | 2.50 | 2.53 | 2.69 | 2.27 | 1.88 | 1.68 | 1.32 | 0.84 | 0.43 | 0.61 | 1.27 | 1.57 | 2.13 | 2.09 | 1.88 |
EPS (Diluted) | 3.27 | 3.31 | 2.54 | 2.41 | 2.23 | 2.29 | 2.46 | 2.49 | 2.65 | 2.23 | 1.85 | 1.66 | 1.31 | 0.84 | 0.43 | 0.60 | 1.25 | 1.55 | 2.11 | 2.07 | 1.85 |
EBITDA | 346.51M | 337.4M | 316.66M | 298.12M | 252.51M | 260.31M | 240.61M | 237.95M | 272.82M | 249.34M | 234.24M | 227.33M | 205.21M | 178.42M | 135.14M | 136.4M | 168.02M | 174.03M | 228.07M | 234.83M | 231.94M |
EBIT | 231.3M | 221.82M | 180.43M | 167.37M | 150.98M | 164.88M | 170.19M | 167.5M | 178.93M | 156.03M | 139.98M | 132.35M | 110.13M | 80.75M | 40.38M | 45.15M | 79.42M | 89.75M | 136.93M | 137.41M | 128.37M |
Depreciation & Amortization | 115.21M | 115.59M | 115.02M | 109.52M | 87.53M | 81.42M | 77.64M | 77.68M | 93.89M | 93.31M | 94.27M | 95.06M | 95.16M | 97.75M | 94.84M | 91.25M | 88.6M | 84.29M | 91.14M | 97.42M | 103.58M |